...
CCRNMICRO

Cross Country Healthcare, Inc.

HealthcareMedical - Care Facilities
$8.70
$0.00(-0.80%)
52W$7.43
$17.30
FinancialsValuationvs SOLV
Updated Mar 2, 12:00 AM
RSI53
RS Rating25/99
Beta0.43
Volatility46%
F-Score4/9
Mkt Cap$281M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Cross Country Healthcare, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 25), showing significant lag compared to the market leaders. Earnings contraction of 294% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
25
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.43
vs S&P 500
LOW VOL
52W Position
13%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$8.55
50 SMA > 100 SMA$9.93
100 SMA > 150 SMA$11.07
150 SMA > 200 SMA$11.61

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$8.61+1.08%ABOVE
50 SMA$8.55+1.76%ABOVE
100 SMA$9.93-12.40%BELOW
150 SMA$11.07-21.43%BELOW
200 SMA$11.61-25.04%BELOW

Price Performance

1D-0.8%
1W+1.5%
1M-4.1%
3M-15.2%
6M-34.9%
YTD+7.9%
1Y-49.3%
3Y-31.0%
52-Week Trading Range13% from low
$8.70
52W Low$7.43
52W High$17.30

Technical Indicators

RSI (14)NEUTRAL
53.2
305070
VCP ScoreCOOL
6/10
Base depth: 29.5%

Risk Profile

Beta
0.43
52W Vol
46%
ATR
$0.32
Max DD (1Y)
-56%

Volume Analysis

Today
8
50D Avg
490.1K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24-146%
$-0.12
Q1'25-126%
$-0.02
Q2'25+57%
$-0.20
Q3'25-294%
$-0.15
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+8.08%
5 Years:+10.33%
3 Years:-7.11%
TTM:-22.14%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:-7.93%

Stock Price CAGR

10 Years:-3.49%
5 Years:-6.01%
3 Years:-30.97%
1 Year:-49.30%

Return on Equity

10Y Avg:10.2%
5Y Avg:22.4%
3Y Avg:20.5%
Last Year:-3.8%

Key Metrics

Market Cap$281M
Gross Margin20.4%
Net Margin-1.1%
Piotroski F-Score4/9

More CCRN Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

CCRN vs SOLVSOLVHCSGAMNCCEL

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 25 meansCCRN outperformed 25% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.43 means 57% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 4/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is CCRN in an uptrend right now?

CCRN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is CCRN overbought or oversold?

CCRN's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.

Is CCRN outperforming the market?

CCRN has a Relative Strength (RS) Rating of 25 out of 99. CCRN is currently lagging the broader market.

Where is CCRN in its 52-week range?

CCRN is trading at $8.70, which is 50% of its 52-week high ($17.30) and 13% above its 52-week low ($7.43).

How volatile is CCRN?

CCRN has a Beta of 0.43 and 52-week volatility of 46%. It's less volatile than the S&P 500 - generally more stable.